February 14, 2020

2021 E&M Changes - Risk in the MDM

Next year will see the implementation of significant changes to E&M guidelines, reducing the emphasis on the history and exam components while highlighting medical decision making (M.D.M.). In our last audit tip on the E&M changes, we discussed the second of the three sections of MDM, the amount and complexity of data reviewed.

In this tip, we will address another section of M.D.M. - risk.

Currently, the 1995 and 1997 documentation guidelines title this section of MDM "Risk of Significant Complications, Morbidity, and/or Mortality," going on to say that it is "based on the risks associated with the presenting problem(s), the diagnostic procedure(s), and the possible management options." In 2021, CPT changes this heading to "Risk of Complications and/or Morbidity or Mortality of Patient Management." This title is further defined as being based on "patient management decisions made at the visit, associated with the patient's problem(s), the diagnostic procedure(s), treatment(s). This includes the possible management options selected and those considered, but not selected, after shared medical decision making with the patient and/or family."

Today, we score this section of MDM using the Table of Risk. Beginning in 2021, we will only use a modified version of the Management Options column of the Table of Risk. For example, the information found in this column for moderate risk is:

Moderate risk of morbidity from additional diagnostic testing or treatment

Examples only:  
  • Prescription drug management
  • Decision regarding minor surgery with identified patient or procedure risk factors
  • Decision regarding elective major
  • surgery without identified patient or procedure risk factors
  • Diagnosis or treatment significantly limited by social determinants of health
As we can see in the example, there are some familiar inclusions such as prescription drug management and decisions regarding surgery, but look at the last item (in italics). You may be wondering how we will know if a visit is significantly limited by social determinants of health. Or, better yet, what is a social determinant of health?

CPT to the rescue: As we discovered in the first two articles in this series, definitions are provided in the new CPT guidelines to guide us. Isn't that what guidelines are meant to do after all? Social determinants of health are no exception. CPT defines this as "Economic and social conditions that influence the health of people and communities. Examples may include food or housing insecurity." In addition to the definition for this new concept we will have to consider, we also get a very detailed definition for an area that stirs much disagreement among coders, auditors, and providers: drug therapy requiring intensive monitoring for toxicity.

The 2021 definition for this item is given as:

"A drug that requires intensive monitoring is a therapeutic agent that has the potential to cause serious morbidity or death. The monitoring is performed for assessment of these adverse effects and not primarily for assessment of therapeutic efficacy. The monitoring should be that which is generally accepted practice for the agent, but may be patient specific in some cases. Intensive monitoring may be long-term or short term. Long-term intensive monitoring is not less than quarterly. The monitoring may be by a lab test, a physiologic test or imaging. Monitoring by history or examination does not qualify. The monitoring affects the level of medical decision making in an encounter in which it is considered in the management of the patient. Examples may include monitoring for a cytopenia in the use of an antineoplastic agent between dose cycles or the short-term intensive monitoring of electrolytes and renal function in a patient who is undergoing diuresis. Examples of monitoring that does not qualify include monitoring glucose levels during insulin therapy as the primary reason is the therapeutic effect (even if hypoglycemia is a concern); or annual electrolytes and renal function for a patient on a diuretic as the frequency does not meet the threshold."

This definition not only tells us what intensive monitoring is (performed for assessment of these adverse effects), but also what it isn't (not primarily for assessment of therapeutic efficacy). It seems that we often want to assign high risk today based solely on the fact that the patient is on a high-risk medication without consideration of whether there is intensive monitoring during the visit. This clarification provided by CPT in the 2021 guidelines for office or other outpatient visits could actually guide our understanding going forward.

Consider this. The 1995 and 1997 guidelines use the term "complexity" 11 times in the descriptions of MDM. This seems to indicate they intended the level of MDM to equate to the picture of complexity the provider documented. Now compare the 2021 E&M changes we have explored so far. I believe it is easy to see that the way we will score MDM for office visits in the future more appropriately aligns with the intent of the outdated guidelines than our current MDM scoring tool. Finally, consider the one thing that hasn't changed. The Medicare Claims Processing Manual (chapter 12, section 30.6.1) still states that the "medical necessity of a service is the overarching criterion for payment in addition to the individual requirements of a CPT code. It would not be medically necessary or appropriate to bill a higher level of evaluation and management service when a lower level of service is warranted. The volume of documentation should not be the primary influence upon which a specific level of service is billed."

By eliminating the requirement to score history and exam components and focusing instead on the complexity of the visit documented through the elements of MDM, it seems stars will finally align for CPT and CMS.

Join us next time for the final segment in this series when we put it all together to compare examples of MDM scored using the current E&M tool vs. the 2021 MDM Table. In the meantime, you can find the complete story on the coming changes at  https://www.ama-assn.org/system/files/2019-06/cpt-office-prolonged-svs-code-changes.pdf.

This Week's Audit Tip Written By:


Pam is a Senior Compliance Consultant with our parent company, DoctorsManagement

Our weekly auditing & compliance tip emails are available to anyone who could benefit from this information.  If you know someone who would like to receive these emails, invite them to sign up.  

Click the image above
to be added to our email list!

NAMAS needs your help in capturing salary information for 2019 and developing standards for the industry.  This is the information that YOU as an auditor need to share with your employer!

Everyone who participates will be entered into a drawing for a chance to win one of many prizes! One winner will receive a $100 Visa gift card , two winners will each receive a  $25 Starbucks gift card , and one lucky winner will receive a  FREE registration to the NAMAS 12th Annual Auditing & Compliance Conference in December!

Survey ends on March 15, 2020. Winners will be selected and contacted by a NAMAS representative. Survey findings will be released no later than March 31, 2020.

Give Us a Try and 
Earn 4 CEUs!

Sample what a NAMAS membership can do for you with our FREE 4-week LITE Trial membership!

During your trial, you'll receive access to weekly webinars for a chance to earn up to 
4 CEUs, weekly auditing and compliance tips, and even an online sample of  BCAdvantage magazine!

Make sure you are up-to-date with the latest compliance topics! 

Click the image above to read the Compliance Blog from Sean Weiss,  Chief Compliance Officer with DoctorsManagment.

Early Bird Registration Ends TOMORROW

We're excited to announce the 
on March 11-12, 2020!

It's 2 days (12:00pm-4:00pm EST each day) packed full of comprehensive sessions in an interactive and fun format!

More Than Just A Webinar!

We're bringing the "Conference Experience" to you - no travel required. You'll learn from the best in the industry, interact with the speakers, and ask questions to really dig deep into topics specific to auditing and compliance.

Unsure of what to expect?

Here's a sample of Shannon Deconda's session on Prolonged Services from the  2019 Virtual Conference: 

Use coupon code VIRTUAL to take $100 OFF your registration until  FEBRUARY 15, 2020.

for more information and to register

  THE NAMAS E/M Auditing BootCamp is an accelerated auditing training specific to EmM auditing. Learn about audit policies, get clarity on documentation current and future guidelines, medical decision making, medical necessity and more.  Plus, during this training program you will have the opportunity to  earn our Certified Evaluation and Management Auditor (CEMA) CREDENTIAL!

Changes Are Coming
Be ahead of the curve with this E&M Comparison Chart

  Clear the confusion! This easy to understand chart will detail all the upcoming E&M changes. Each component is defined and all changes are explained in depth.

Medical Necessity Leveling Chart is included 
with the double-sided laminated version for only $7.99 each -  Order Here

Bulk pricing is available. Contact NAMAS at 877-418-5564 
for pricing and more information.

  As a NAMAS member, you'll receive access  to monthly webinars for CEUs (including those  hard to find CPMA CEUs!), a subscription to BC Advantage magazine, discounts on products and NAMAS training events, and much, much more!

We offer 4 membership levels -
choose the one that best suits your needs!

    For added convenience, NAMAS accepts  PayPal, PayPal Credit, quarterly and monthly payments of membership dues.

For both new auditors AND seasoned auditors with years of experience, there is no better resource. This manual will review current E/M guidance, as well as  prepare you for what lies ahead in 2021 ! Workbook is included in your order. 

NAMAS is proud to offer the following
webinars in February, 2020:

Breached- Are You Prepared?
(Compliance Webinar Series)
February 18, 2020 @ 2pm EDT
Speaker: Nicholas Goodwin, Esq.

Structuring an Effective Compliance Program: The Ins & Outs of How to Ensure You're on the Right Track
(Steps to An Effective Compliance Program Webinar Series)
February 19, 2020 @2pm EDT
Speaker: Robert Liles, JD

Auditing Orthopedics
(Specialty Auditing Webinar Series)
February 25, 2020 @2pm EDT
Speaker: Pam Vanderbilt, CPC, CPC-I, CPMA, CEMA, CEMA-O
Follow NAMAS on Social Media! 

Like us on Facebook   Follow us on Twitter   View our profile on LinkedIn